SCHEMBL2907046

SCHEMBL2907046

Nc1cc(Cl)c(F)cc1NC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.41
FADS1 O60427 1/20 0.40
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC2A1 P11166 1/20 0.37
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
GFER P55789 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 1/20 0.35
FABP4 P15090 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27597105 0.80 CD44 (0.52) HDAC1KMT2AMEN1NPC1RAB9A
SCHEMBL2849268 0.79 GAA (0.38) HDAC1FADS1KMT2AMEN1NPC1
SCHEMBL27615938 0.78 KDR (0.44) KMT2AMEN1RAB9ALMNASMN1; SMN2
SCHEMBL5242446 0.77 HDAC1 (0.44) HDAC1FADS1KMT2AMEN1NPC1
SCHEMBL2353023 0.77 AAK1 (0.40) HDAC1HTTHDAC2CA2
SCHEMBL27597171 0.76 CD44 (0.52) HDAC1KMT2AMEN1NPC1RAB9A
SCHEMBL22637106 0.76 HDAC1 (0.39) HDAC1KDM4EHSD17B10ALDH1A1HDAC2
SCHEMBL22636593 0.75 KDR (0.44) HDAC1KMT2AMEN1RAB9ALMNA
SCHEMBL22636961 0.75 GAA (0.41) HDAC1KMT2AMEN1LMNAHTT
SCHEMBL6610509 0.75 GAA (0.37) HDAC1KMT2ANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed